HomepageSDGR • NASDAQ
add
Schrödinger
Vorige slotkoers
$ 19,29
Dag-range
$ 18,20 - $ 18,90
Jaar-range
$ 16,67 - $ 33,63
Beurswaarde
1,37 mld. USD
Gem. volume
587,35K
Koers/winst
-
Dividendrendement
-
Primaire beurs
NASDAQ
In het nieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
(USD) | sep 2024info | Wijziging j-o-j |
---|---|---|
Opbrengst | 35,29 mln. | -17,10% |
Bedrijfskosten | 86,15 mln. | 7,91% |
Netto inkomsten | -38,14 mln. | 38,51% |
Netto winstmarge | -108,06 | 25,83% |
Winst per aandeel | -0,87 | -24,29% |
EBITDA | -66,86 mln. | -21,75% |
Effectief belastingtarief | 0,24% | — |
Balans
Totale activa
Totale passiva
(USD) | sep 2024info | Wijziging j-o-j |
---|---|---|
Contanten en kortetermijnbeleggingen | 388,68 mln. | -21,68% |
Totale activa | 669,30 mln. | -15,72% |
Totale passiva | 219,87 mln. | -4,64% |
Totaal aandelenvermogen | 449,42 mln. | — |
Uitstaande aandelen | 72,86 mln. | — |
Koers-boekwaardeverhouding | 3,13 | — |
Rendement op activa | -25,20% | — |
Rendement op kapitaal | -29,30% | — |
Kasstroom
Nettomutatie in liquide middelen
(USD) | sep 2024info | Wijziging j-o-j |
---|---|---|
Netto inkomsten | -38,14 mln. | 38,51% |
Operationele kasstroom | -33,26 mln. | 33,41% |
Kasstroom uit beleggingen | 90,70 mln. | 587,00% |
Kasstroom uit financiering | 392,00K | -70,53% |
Nettomutatie in liquide middelen | 57,84 mln. | 263,35% |
Vrije kasstroom | -14,71 mln. | 61,72% |
Over
Schrödinger, Inc. is an international scientific software and biotechnology company that specializes in developing computational tools and software for drug discovery and materials science.
Schrödinger's software is used by pharmaceutical companies, biotech firms, and academic researchers to simulate and model the behavior of molecules at the atomic level. This accelerates the design and develops new drugs and materials more efficiently, reducing the time and cost of bringing them to market.
Schrödinger's software tools include molecular dynamics simulations, free energy calculations, quantum mechanics calculations, and virtual screening tools. The company also offers consulting services and collaborates with partners in the industry to advance the field of computational chemistry and drug discovery. Wikipedia
CEO
Opgericht
1990
Website
Werknemers
867